News
Immunologic colloquium on 19th December 2018
On 19th December 2018 PERSIMUNE invites you to the next immunologic colloquium at Rigshospitalet Department of Infectious Diseases.
Come to hear Dr Sisse Ostrowski share updates on TruCulture and Prof Kjeld Schmiegelow talk about Pediatric oncology research in PERSIMUNE.
All are welcome! Please confirm your attendance by sending an email to persimune.rigshospitalet@regionh.dk

AGENDA

 
New PERSIMUNE publication
Cancer-chemotherapy induced febrile neutropenia: First report from PERSIMUNE on this topic by Nordvig et al, suggesting that the development of febrile neutropenia identifies 

a subgroup of those treated with persistent vulnerability to contract subsequent serious infections. Get the article here

Aagaard et al has developed algorithms able to reliable patients at risk of febrile neutropenia – in press. Future research efforts to better understand the biological mechanisms explaining the vulnerability are required.

 
Immunologic Colloquium 28 November 2018

The next PERSIMUNE Immunologic Colloquium will take place on 28 November 2018 15:30-16:30 at Rigshospitalet Department of Infectious Diseases. Come and hear about Immunotherapy for cancer by Prof Inge Marie Svane and Big data: ethical implications by Prof Gorm Greisen.

All are welcome!

Agenda

 
Vacant position at CHIP/PERSIMUNE as programmer/datamanager

We are looking for a full time programmer for international health research projects in CHIP & PERSIMUNE.
Deadline for application 18th October at 12.00.
Read more about the position and apply here

 
Immunologic colloquium 20th June 2018
The next Immunologic Colloquium will take place 20 June 2018 15.30-16.00 at Rigshospitalet Department of Infectious Diseases.

Agenda

 
NEW PERSIMUNE publication

Rapid estimation of severity of new pandemic influenza types is essential to gauge appropriate level of intervention; the some severe the more intense the intervention. During the 2009 pandemic, Mexican authorities reported substantial severity expressed as a high case fatality rate. In this report, prof Lone Simonsen from CHIP/PERSIMUNE at Righospitalet uses data from a global cohort study lead by INSIGHT to estimate this rate, and find that it was 16 fold lower than initial estimates. These observations can be used to more reliable assess severity in next influenza pandemic. Find the full publication here

 
Next Immunologic Colloquim 18 April

The next Immunologic Colloquium will take place 18 April 2018 15.30-16.30 at Rigshospitalet Department of Infectious Diseases.

Agenda

 
2 day course on Introduction to Cost-effectiveness Analysis for Infectious Diseases
25th - 26th September 2018 at UCL Royal Free Campus, London

The course is for people working in health care settings, academic environments, industry and governmental and non-governmental organisations who wish to achieve a basic understanding of, and be able to interpret, cost effectiveness analyses in the context of infectious diseases, with particular focus on HIV


Read more about the course and sign up here 
CHIP and INSIGHT mourn the loss of Professors David Cooper and Fred Gordin who passed away 18 March
CHIP and INSIGHT mourn the loss of Professors David Cooper and Fred Gordin who passed away on Sunday 18th March 2018.

It is with incredible sadness that we have learned of the passing of two pillars of the INSIGHT network, Fred Gordin in Washington DC and David Cooper in Sydney. 

Fred’s leadership in INSIGHT was unparalleled. He directed the Washington International Coordinating Centre, chaired CPCRA, the SMART and currently the START protocol. Fred’s scientific interests focused on pulmonary disease, and his life-long leadership in tuberculosis research is widely acknowledged. 

David led the Sydney International Coordinating Centre of INSIGHT. David was a central figure in global HIV research for more than three decades and in forming INSIGHT’s studies and research output over the years. The Kirby Institute @ UNSW embodies David’s leadership. As former president of IAS and builder of research structures in Bangkok and elsewhere in Asia, David was an inspiring and visionary leader. 

Fred and David will be sorely missed. Our thoughts are with their friends and families. 

CHIP and INSIGHT honor their legacy.  
CROI 2018
Conference on Retroviruses and Oppertunistic Infections 4 -7 March 2018.
CHIP will be represented at CROI 2018 with 2 presentations.
Please find all presentations here  
Can hypothermia reduce organ dysfunction and mortality in patients with septic shock?
Read more about the results of the latest PERSIMUNE research which was published in Lancet Respiratory Medicine.

 

 
New publication: Results from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study
Marco Gelpi and collegues from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study affiliated with PERSIMUNE recently reported data indicating that even well-treated and in particular older HIV-positive persons remains having a distrinct pro-atherogenic phenotype compared to age and gender matched sections of the general population. This observation renders supports for notions from other sections of research by CHIP and PERSIMUNE, that HIV status is an independent risk factor for cardiovascular disease.  Research focused on identifying mechanisms explaining the development of the phenotype and interventions to contract its likely adverse reactions is underway. 
Abstract  
PhD defence Camilla Hatleberg
Camilla Hatleberg will be defending her PhD Thesis on "Cardiovascular disease in HIV-positive persons: Changes and differences in mortality, -interventions and risk factors; the D:A:D Study"

28th February at 14:00 at Nielsine Nielsen auditoriet in the Mærsk Tower Faculty of Health and Medical Science, University of Copenhagen

Find more information here 
Wall of Fame PERSIMUNE Data Warehouse
Acknowledgement of the huge work done in relation to the establishment of the PERSIMUNE Datawarehouse
See the Wall of Fame for the PERSIMUNE Data Warehouse

 

 

 
Winner of the oral presentation competition at the Danish Transplantation Society

The Danish Transplantation Society held its annual meeting on Wednesday 25th of October 2017. Among the highlights of the scientific program is the oral presentation competition which awards the best presentation with a grant of 10,000 DKK for a conference or research activities. This year, the prize went to Neval Ete Wareham who is an MD and PhD student in PERSIMUNE, working primarily with the MATCH programme. Neval presented the results of the CLASS study, which is the first validated method to reliably classify underlying cause of death in transplant recipients.
Congratulations to Neval.  
PERSIMUNE Immunologic Colloquium 21 June 2017

The next Immunologic Colloquium will take place 21 June, 15.30-17.30
Department of Infectious Diseases 8632, Library room 3rd floor

Please find agenda here

 
Jens Lundgren receives the 2017 Hagedorn Prize
Jens Lundgren receives the 2017 Hagedorn Prize from Novo Nordisk Fonden for his pioneering and internationally recognized research on treatment for people living with HIV.

Press release

Novo Nordisk Fonden website (English)  
New PERSIMUNE publication

Read the latest PERSIMUNE publication
Sustainable HIV treatment in Africa through viral-load-informed differentiated care. L Vojnov et al.

 
Statement by the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Regarding Results
With the availability of the START and TEMPRANO trial results, the Panel’s overall recommendation remains the same: ART is recommended for all HIV-infected patients regardless of pre-treatment CD4 count. However, the strength of the recommendation will be changed to AIa (strong recommendation based on data from randomized controlled trials) for all patients. STATEMENT 
Read the latest news about the START Study results

NIH

Reuters health

IAS2015

DR TV Avisen

EurekAlert

CBC news

Medical Daily

ScienceBlog

Latest News Link

Read all press coverage of the START Study results
here

 
Article on START Study results in New England Journal of Medicine

Read the article on the groundbreaking reults of the START Study, on the benefits of early antiretroviral treatment. Now available online

 
Live streaming from IAS2015 press conference on START study results

Follow the live streaming from IAS2015 press conference for the presentation of the groundbreaking results from the START study

 

 
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention 19-22 July 2015

Presentations

The START study: Design, conduct and main results

Presented by Jens Lundgren, Rigshospitalet, University of Copenhagen, Denmark

Monday 20th July 11-12.30 Ballroom A, Session title: The Strategic Timing of Antiretroviral Treatment (START) Study: Results and their Implications. 
PERSIMUNE Newsletter

The latest PERSIMUNE Newsletter is online. Read more about news and developments here

 
BREAKING NEWS: Results of the START study
START, one of the largest ongoing HIV studies, has announced early results regarding the long-debated question of when to start HIV-infected individuals on treatment. 

Read the press release from the NIH here

Have questions about the study results and what they mean for HIV patients? Find answers on the NIH Q & A page

Go to CHIP's START news page or click on the links below to read what other news sources around the world are saying about the groundbreaking results of the START study: 


UNAIDS

The New York Times

BBC news

ScienceMag.org

Groundup.org

ibase.info 
New Publication of interest

Article on how Amanda Mocroft and colleagues provide a HIV-specific risk score to balance the potential benefits and harms of nephrotoxic ART, based on data from the DAD study. Addressing the need for personalized decision making in the clinic. Read the article

 
Informed Consent form now available in several languages

The PERSIMUNE Informed Consent Form is now available in 10 languages:

Danish, English, Arabic, Farsi, Greenlandic, Faroese, Bosnian, Urdu, Somali and Turkish

 
Copenhagen Summer University

Copenhagen Summer University

A 5 day course in Personalised Medicine - the future treatment paradigm 17th-21st August. Dealine for registration is 28th of May.

Read more about the course and sign up here

Copenhagen Summer University for working professionals

English

Danish

 

 
PERSIMUNE Newsletter

Read the latest Newsletter for updates on PERSIMUNE
Newsletter 23 April

 
First PERSIMUNE article

The first PERSIMUNE article is on the cover of PLoS Medicine "Development and Validation of a Risk Score for Chronic Kidney Disease in HIV infection Using Prospective Cohort Data from the D:A:D study"

An open access tool to calculate individual patient risk of chronic kidney disease was released in conjunction with the publication of the article

 

 

 
Approval from National Danish Data Authorities

PERSIMUNE has now received approval from the National Danish Data Authorities to commence the recruitment of patients prospectively into the PM platform incl enrolment into the PM biobank. Find Informed Consent Form and Guidance on how to start enrolment here

 
PERSIMUNE Project Proposal

The PERSIMUNE Project Proposal Form is now available on the website 

 
PERSIMUNE Newsletter

Newsletter 24 February

 
Social Media guide

PERSIMUNE communicates through social media to increase awareness about the new research platform and to share and disseminate findings, events and more. We encourage feedback, discussion and knowledge sharing via social media. Read more on why and how here Social Media guide.pdf

 
PERSIMUNE Scientific retreat

Agenda for PERSIMUNE Scientific retreat 3rd and 4th February.

PERSIMUNE workshop and opening 3rd and 4th feb 2015.pdf 
Programme for the official opening of PERSIMUNE 4th February 2.30 pm

Programme for official opening of PERSIMUNE 

Programme Invitation_2015JAN27.pdf

 
OFFICIAL OPENING OF THE DANISH NATIONAL RESEARCH FOUNDATION CENTRE OF EXCELLENCE PERSIMUNE

The official opening ceremony of PERSIMUNE will take place on 4th February 2015 at 14:30, Øster Allé 56, 5th floor. All are welcome! Kindly reply to: pa-lundgren.rigshospitalet@regionh.dk 
For more information please click here